CALGARY, Sept. 26, 2011 /CNW/ - The Alberta Securities Commission (ASC)
has found that it is in the public interest to cease trade Afexa Life
Sciences Inc.'s shareholder rights plans as of 12:01 a.m. MST on
September 30, 2011.
An ASC panel issued the cease trade order after considering an
application by Paladin Labs Inc.
A copy of the Ceased Trade Order has been posted on the ASC website at www.albertasecurities.com. The ASC panel will release its written decision at a later date.
The ASC is the regulatory agency responsible for administering the
province's securities laws. It is entrusted with fostering a fair and
efficient capital market in Alberta and protecting investors. As a
member of the Canadian Securities Administrators, the ASC works to
improve, coordinate and harmonize the regulation of Canada's capital
SOURCE Alberta Securities Commission
For further information:
| For Media Inquiries: |
| Mark Dickey |
Senior Communications Advisor
| || |
| For Investor Inquiries: |
| ASC Public Inquiries |
Toll Free 1-877-355-4488